NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Biobank For MS And Other Demyelinating Diseases
Biobank For MS And Other Demyelinating Diseases

NCT00445367

Active Not RecruitingN/A

Sponsor: Accelerated Cure Project for Multiple Sclerosis

Conditions: Multiple Sclerosis, Transverse Myelitis, Neuromyelitis Optica, Acute Disseminated Encephalomyelitis, Optic Neuritis

Countries: United States

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Eligibility overview

Sex: ALL

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent
* willing to provide up to 110 ml (50 ml for \< 18 years old) of blood via venipuncture
* experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON

Exclusion Criteria:

* history of blood borne pathogens
* allogeneic bone marrow transplant
* clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).
* weight less than 37 pounds
Locations (10)
  • Phoenix, Arizona, United States
  • Stanford, California, United States
  • Aurora, Colorado, United States
  • Atlanta, Georgia, United States
  • Baltimore, Maryland, United States
  • Boston, Massachusetts, United States
  • Worcester, Massachusetts, United States
  • New York, New York, United States
  • Columbus, Ohio, United States
  • Dallas, Texas, United States